Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Yunovia Announces IND Approval by the MFDS to Initiate Phase 1 MAD Study for the Small Molecule GLP-1 Agonist 2024-08-28 10:43
Ildong Pharmaceutical starts Phase 1 study of new diabetes therapy in Germany 2021-07-01 21:00
1